Suspension Neural Crest Cell Induction Under Xeno-Free Culture

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for inducing neural crest cells from pluripotent stem cells are time-consuming, typically taking at least 7 days, and often require adherent culture under non-xeno-free conditions.

Innovation Solution

A method involving suspension culture of pluripotent stem cells in a culture medium containing an ALK inhibitor and bone morphogenetic protein, followed by culture in a medium with a GSK-3β inhibitor, which can induce neural crest cells in as little as 4 days, with high efficiency and under xeno-free conditions, and includes optional shaking or stirred culture.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If conventional adherent culture methods are used to induce neural crest cells from pluripotent stem cells, then the induction can be achieved, but the process takes at least 7 days and often requires non-xeno-free conditions

Engineering Contradiction:
Improveinduction timeVSAvoidinduction efficiency
Core Design Contradiction:
Loss of timeVSReliability

Solution Approach 1:

The patent changes the culture method from adherent to suspension culture, and modifies the culture medium composition to include specific inhibitors (SB431542, CHIR99021) and growth factors (bFGF, EGF) at optimized concentrations. These parameter changes enable neural crest cell induction in 4 days under xeno-free conditions while maintaining high efficiency

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent transitions from two-dimensional adherent culture to three-dimensional suspension culture, allowing cells to form aggregates in a different spatial dimension. This dimensional change accelerates induction kinetics and enables xeno-free conditions

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If the culture period is extended to improve neural crest cell induction under xeno-free conditions, then induction efficiency improves, but the time required increases to 10 days

Engineering Contradiction:
Improveinduction efficiencyVSAvoidculture period
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent optimizes the concentrations of SB431542 (1-10 μM), CHIR99021 (0.1-10 μM), bFGF (1-20 ng/mL), and EGF (1-20 ng/mL) in the culture medium, along with adjusting pH (6.5-7.5) and temperature (37°C). These parameter optimizations enable high-efficiency neural crest cell induction in only 4 days under xeno-free conditions

Inventive Principle:
Principle #35Parameter changes

3Loss of time

If suspension culture is used instead of adherent culture, then the induction time is reduced and xeno-free conditions are achieved, but the culture method complexity increases

Engineering Contradiction:
Improveinduction timeVSAvoidculture method complexity
Core Design Contradiction:
Loss of timeVSDevice complexity

Solution Approach 1:

The patent employs suspension culture where pluripotent stem cells form three-dimensional aggregates in liquid medium rather than adhering to surfaces. This dimensional transition simplifies the culture system by eliminating the need for specialized adherent surfaces while reducing induction time to 4 days and enabling xeno-free conditions

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The suspension culture system serves multiple functions: it enables rapid neural crest cell induction, maintains xeno-free conditions, allows for scalable production, and facilitates easy harvesting of cell aggregates. This multi-functionality compensates for the perceived complexity by providing integrated benefits

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentEP4715043A1Method for producing neural crest cells
Publication Date: 2026.03.25 KYOTO UNIV
  • EP4715043A1 patent drawingFigure 1~2C
  • EP4715043A1 patent drawingFigure 3~4
  • EP4715043A1 patent drawingFigure 5~6

AI summary

The present invention provides a method for producing a neural crest cell from a pluripotent stem cell, the method comprising: (1) a step of suspension-culturing the pluripotent stem cell in a culture medium containing an ALK inhibitor and a bone morphogenetic protein; and (2) a step of suspension-culturing the cell in a culture medium containing the ALK inhibitor and a GSK-3β inhibitor.